12/2
07:08 am
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $12.00 price target on the stock.
Low
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $12.00 price target on the stock.
12/2
06:39 am
vygr
Rating for VYGR
Low
Report
Rating for VYGR
12/2
06:39 am
vygr
Rating for VYGR
Low
Report
Rating for VYGR
11/29
09:06 am
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) is now covered by analysts at Wedbush. They set an "outperform" rating and a $11.00 price target on the stock.
High
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) is now covered by analysts at Wedbush. They set an "outperform" rating and a $11.00 price target on the stock.
11/29
09:06 am
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) is now covered by analysts at Wedbush. They set an "outperform" rating and a $11.00 price target on the stock.
High
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) is now covered by analysts at Wedbush. They set an "outperform" rating and a $11.00 price target on the stock.
11/14
11:13 am
vygr
Rating for VYGR
Medium
Report
Rating for VYGR
11/14
08:15 am
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Medium
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
10/24
03:27 pm
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Low
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
10/16
08:24 am
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $15.00 price target on the stock.
High
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $15.00 price target on the stock.
10/16
07:52 am
vygr
Rating for VYGR
High
Report
Rating for VYGR